Vontobel Holding’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.7M | Sell |
379,656
-5,316
| -1% | -$416K | 0.09% | 147 |
|
|
2025
Q1 | $27.9M | Sell |
384,972
-14,903
| -4% | -$1.08M | 0.1% | 140 |
|
|
2024
Q4 | $29.6M | Sell |
399,875
-39,231
| -9% | -$2.9M | 0.1% | 131 |
|
|
2024
Q3 | $29M | Buy |
439,106
+23,560
| +6% | +$1.55M | 0.09% | 139 |
|
|
2024
Q2 | $38.4M | Sell |
415,546
-13,108
| -3% | -$1.21M | 0.12% | 112 |
|
|
2024
Q1 | $41M | Buy |
428,654
+30,230
| +8% | +$2.89M | 0.33% | 83 |
|
|
2023
Q4 | $30.4M | Sell |
398,424
-17,175
| -4% | -$1.31M | 0.25% | 100 |
|
|
2023
Q3 | $28.8M | Sell |
415,599
-4,424
| -1% | -$306K | 0.27% | 96 |
|
|
2023
Q2 | $39.6M | Buy |
420,023
+28,537
| +7% | +$2.69M | 0.35% | 75 |
|
|
2023
Q1 | $32.4M | Sell |
391,486
-31,006
| -7% | -$2.57M | 0.3% | 90 |
|
|
2022
Q4 | $30.9M | Buy |
422,492
+102,822
| +32% | +$7.52M | 0.31% | 84 |
|
|
2022
Q3 | $26.8M | Sell |
319,670
-7,395
| -2% | -$620K | 0.31% | 85 |
|
|
2022
Q2 | $31.4M | Buy |
327,065
+10,775
| +3% | +$1.03M | 0.34% | 70 |
|
|
2022
Q1 | $37M | Buy |
316,290
+3,784
| +1% | +$443K | 0.32% | 66 |
|
|
2021
Q4 | $40.8M | Buy |
312,506
+50,694
| +19% | +$6.62M | 0.34% | 65 |
|
|
2021
Q3 | $29.6M | Buy |
261,812
+18,812
| +8% | +$2.13M | 0.26% | 84 |
|
|
2021
Q2 | $25.2M | Buy |
243,000
+40,823
| +20% | +$4.23M | 0.22% | 99 |
|
|
2021
Q1 | $16.9M | Buy |
202,177
+3,752
| +2% | +$314K | 0.13% | 120 |
|
|
2020
Q4 | $17.1M | Buy |
+198,425
| New | +$17.1M | 0.11% | 111 |
|